FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/074263 [Registered on: 24/09/2024] Trial Registered Prospectively
Last Modified On: 18/09/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A clinical study to compare haritakyadi churna and avipattikara churna in the management of hyper acidity 
Scientific Title of Study   A comparative clinical study on the efficacy of haritakyadi churna and avipattikara churna in the management of urdhwaga amlapitta w.s.r.to non ulcer dyspepsia 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Prajakta Haridas Jori  
Designation  PG scholar 
Affiliation  sst ayurved medical college sangamner 
Address  OPD number 5 kayachikitsa OPD ground floor sst ayurved hospital sangamner tal sangamner dist ahmadnagar

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9284649948  
Fax    
Email  prajaktajori6@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Nilesh Dere 
Designation  Professor 
Affiliation  sst ayurved medical college sangamner 
Address  OPD number 5 kayachikitsa OPD ground floor sst ayurved hospital sangamner tal sangamner dist ahmadnagar

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9271292389  
Fax    
Email  dr.nilesh.dere@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Nilesh Dere 
Designation  Professor 
Affiliation  sst ayurved medical college sangamner 
Address  OPD number 5 kayachikitsa OPD ground floor sst ayurved hospital sangamner tal sangamner dist ahmadnagar

Ahmadnagar
MAHARASHTRA
422605
India 
Phone  9271292389  
Fax    
Email  dr.nilesh.dere@gmail.com  
 
Source of Monetary or Material Support  
sst ayurved medical college sangamner tal. sangamner dist. ahmadnagar maharashtra pincode 422605 
 
Primary Sponsor  
Name  Dr Prajakta Haridas Jori 
Address  OPD no 5 kayachikitsa OPD Ground Floor Sst Ayurved Hospital sangamner Tal sangamner Dist ahmadnagar 422605 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Prajakta Haridas Jori  Sst Ayurved Hospital sangamner   OPD number 5 kayachikitsa OPD ground floor sst ayurved hospital sangamner tal. sangamner dist. ahmadnagar
Ahmadnagar
MAHARASHTRA 
9284649948

prajaktajori6@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
sst ayurved mahavidyalaya sangamner institutional ethics committe  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K219||Gastro-esophageal reflux disease without esophagitis. Ayurveda Condition: URDHVAGATA-AMLAPITTAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Haritakyadi churna, Reference: Bhavprakash nighantu, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 4 Weeks, anupAna/sahapAna: Yes(details: koshna jala), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Avipattikara churna, Reference: bhaishjya ratnawali, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 4 Weeks, anupAna/sahapAna: Yes(details: koshna jala), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1 Presenting with classical symptoms of amlapitta such as tikta-amlodgara (sour & bitter belching)
2 Hrita-Kantha Daha
3 Aruchi (Anorexia)
4 Utklesha(Nausea)
5 Avipaka(Indigestion)
6 Klama (Tiredness)
7 Gauravata(Abdominal Fullness) 
 
ExclusionCriteria 
Details  1 known case of bleeding disorders
2 Patients suffering from known systemic illness which interfere with course of treatment
3 Diagnosed case of Helicobacter pylori
4 Pregnant women, lactating mother, alcoholic persons
5 known case of High risk Diseases such as diabetes,HTN
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
to studt the efficacy of Haritakyadi churna in the management of urdhwaga amlapitta  4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
to compare the effect of haritakyadi churna & avipattikara churna in the management of urdhwaga amlapitta  4 weeks 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   16/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   As we see the number of patients with hyper acidity are increased now a days so this study will help the patients for reducing hyper acidity and symptoms like heart burn and nausea. This study is A comparative clinical study on the efficacy of haritakyadi churna and avipattikara churna in the management of urdhwaga amlapitta w.s.r.to non ulcer dyspepsia . both drugs are given in the form of powder for the diagnosed cases of urdhwaga amlapitta for 4 weeks. 40 patients in each group will be studied. Study will be conducted in India. Outcome of study will be asses on reducing hyper acidity and symptoms like heart burn and nausea 
Close